Abstract
Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self-managing their medications. Exenatide long-acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide-LAR may be considered for use in carefully selected elderly individuals.
Author supplied keywords
Cite
CITATION STYLE
APA
Takenaka, K., & Nishitani, R. (2019). Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long-acting release. Clinical Case Reports, 7(5), 981–983. https://doi.org/10.1002/ccr3.2139
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free